Can Benzos Cause Dementia?

Understanding the Risks and Implications

Benzodiazepines, commonly referred to as benzos, are a class of medications prescribed for anxiety, seizures, and insomnia. While these drugs can be effective in the short term, a growing body of research raises concerns about their long-term safety in elderly patients. One question is gaining attention: Can benzodiazepines cause dementia?

This article explores the relationship between dementia and benzodiazepines using evidence from several observational studies, systematic reviews, and more to help you understand the risks and how to protect your brain health.

Key Takeaways

  • Benzodiazepines have a complex and concerning relationship with dementia risk, particularly with long-term use.
  • Studies suggest a modest to moderate increase in dementia risk among long-term benzodiazepine users.
  • The effects of benzodiazepine use vary by type, duration, and individual health, with potential for serious side effects and challenging withdrawal symptoms.
  • If you are taking benzodiazepines and are concerned about memory or dementia, discussing your treatment plan with your healthcare provider is crucial. For safe and personalized care, including medical detox and ongoing support, Charles River Recovery is available to help; call (844) 441-0455 to learn more.

How Do Benzos Work?

When someone takes a benzodiazepine medication, it enhances the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that blocks nerve impulses in the brain.

As central nervous system depressants, benzos produce a calming effect that slows down brain function, helping to reduce anxiety disorders, prevent sleep disorders, and promote rest. This mechanism is central to how benzos produce a sedative or tranquilizing effect.

What Is Dementia?

Dementia refers to a group of symptoms that affect memory, thinking, behavior, and social abilities. It gradually interferes with a person’s ability to perform everyday activities. Dementia diagnosis is typically based on criteria from the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).

Alzheimer’s disease is the most common form of dementia, and while no cure exists, symptoms typically start mild and worsen over time.

Although dementia presents differently in individuals, some universal symptoms include:

  • Paranoia or suspicious thoughts
  • Mood swings or emotional instability
  • Confusion or disorientation
  • Memory loss and forgetfulness
  • Difficulty maintaining conversations
  • Sleep disturbances
  • Impaired decision-making or problem-solving

Other types of dementia include Lewy body dementia, vascular dementia, and frontotemporal dementia. In many cases, early symptoms overlap with signs of mental health disorders and medication side effects, making diagnosis more complex.

What Do Studies Reveal About the Link Between Benzodiazepines and Dementia Risk?

Researchers continue to investigate the relationship between chronic benzodiazepine use and the incidence of dementia. While some studies highlight a potential benzodiazepine dementia disorders link, others found little evidence of a causal relationship, and some warn that lower cognitive ability raises the risk of benzodiazepine use in adulthood.

The Caerphilly Prospective Study by Gallacher et al. in 2011 found a significant positive link between benzo use and dementia, with the strongest relationship observed for cumulative use over four years.

Prospective cohort studies found that participants who took prescribed benzodiazepines, especially for extended periods, were more likely to develop dementia than those who did not. For instance, a statistically significant association was reported in a 2014 BMJ study, where researchers observed up to a 51% increase in the risk of dementia following benzo usage, especially among long-term users.

However, other researchers argue that early symptoms of dementia, such as anxiety or sleep disturbances, might lead to benzodiazepine prescriptions, complicating efforts to determine a true causal relationship. To address these confounding variables, sensitivity analyses were used to adjust for pre-existing conditions and compare outcomes more accurately.

When comparing groups of benzo users and non-users, dementia risk is often assessed using standardized cognitive testing, diagnosis criteria, and follow-up evaluations. The results vary, but across multiple reviews, dementia risk compared between long-term users and control groups tends to lean toward a modest to moderate increase in risk.

This growing body of research underscores the importance of caution, especially for dementia prevention in older adults. This then makes it essential for anyone currently prescribed benzodiazepines to work closely with their healthcare provider to evaluate the necessity, dose, and duration of their treatment plan.

Types of Benzos

Benzodiazepines are classified based on how long they act in the body. These include:

  • Short-acting benzos: Quick onset, short duration (e.g., Alprazolam – used for anxiety and panic disorders)
  • Intermediate-acting benzos: Moderate duration (e.g., Lorazepam – used for anxiety and seizures)
  • Long-acting benzos: Remain active for an extended period (e.g., Diazepam – used for anxiety, muscle spasms, alcohol withdrawal, and seizures)

Each type varies in duration, potency, and specific clinical use.

Possible Effects of Using Benzos

While benzodiazepines can relieve symptoms in the short term, long-term benzodiazepine users may face serious side effects. These can vary based on the dosage, duration, and the individual’s health.

Common adverse effects may include:

  • Syncope
  • Tremors
  • Drowsiness
  • Confusion
  • Respiratory depression
  • Headache

Long-term effects may include:

  • Cognitive decline
  • Memory loss
  • Addiction or dependence

These effects are particularly concerning for elderly patients, whose bodies metabolize drugs more slowly and may be more sensitive to side effects.

Benzos Withdrawal Symptoms

Withdrawal from benzodiazepines can occur even with prescribed use, especially if taken for an extended period. Tapering off the medication gradually, under medical supervision, is essential to reduce risks.

Common benzo withdrawal symptoms include:

  • Anxiety and irritability
  • Muscle pain or stiffness
  • Dizziness or headaches
  • Sleep issues or nightmares
  • Hallucinations or paranoia
  • Seizures (in severe cases)

Withdrawal symptoms can sometimes mimic early signs of dementia, making it important to distinguish between the two with professional help.

Signs of Benzos Overdose

An overdose can occur with intentional misuse or accidentally, particularly when benzos are combined with alcohol or other depressants.

Between 2019 and 2020, emergency visits for benzodiazepine overdoses rose by 23.7%, involving opioids in 34.4% of cases and without opioids in 21.0%. Overdose deaths related to benzodiazepines increased by 21.8% for prescription and 519.6% for illicit use from April to June 2019 to the same period in 2020. In the first half of 2020, 92.7% of benzodiazepine overdose deaths involved opioids.

Symptoms of benzodiazepine overdose and toxicity include:

  • Extreme confusion
  • Trembling or shakiness
  • Slurred speech
  • Severe drowsiness or sedation
  • Aggression or agitation
  • Loss of consciousness or coma

Treatment and Recovery Options for Benzos Addiction

Overcoming benzodiazepine addiction requires a comprehensive treatment plan. A combination of medical intervention, behavioral therapy, and social support offers the best chance for recovery.

Personalized Recovery for Benzodiazepine Dependency at Charles River Recovery

If you’re struggling with benzodiazepine use or worried about memory and focus, Charles River Recovery offers safe, personalized care. Our team understands the risks and will help you taper off safely, with support every step of the way.

Located in Weston, MA, we provide 24/7 medical detox, therapy, and ongoing support for your recovery. We treat the whole person, mind, body, and brain.

Call us anytime at (844) 441‑0455 to get started. Let’s take the next step together.

Inpatient and Outpatient Rehab Programs

At Charles River Recovery, treatment begins with a safe detox process followed by therapy and peer support. Inpatient rehab provides 24/7 care and is ideal for severe cases, while outpatient programs are more flexible for milder addictions.

Counseling and Behavioral Therapy

Individual and group counseling help clients understand the root causes of their addiction and teach healthier coping mechanisms. These therapies are key to long-term recovery, especially in managing co-occurring mental health issues such as depression or anxiety.

Recovery success depends on many factors, including the individual’s motivation, the support they receive, and the appropriateness of the treatment plan.

What Should You Do If You’re Taking Benzos?

No one should take benzodiazepines without a doctor’s prescription. If you’re prescribed benzos, especially as a senior or someone with a family history of dementia, discuss your risks in detail with your healthcare provider.

Make sure to:

  • Share any family history of dementia or alzheimer’s disease
  • Disclose all medications and health conditions
  • Report any changes in memory, mood, or behavior
  • Ask if non-benzodiazepine alternatives or lower doses are appropriate

It’s equally important for caregivers and loved ones to observe and document any unusual changes in the person taking benzos.

If there’s ever a suspicion of misuse, overdose, or cognitive changes, seek medical help immediately.

Frequently Asked Questions

Are certain benzodiazepines more likely to cause dementia than others?

Some studies suggest that long-acting benzodiazepines (like diazepam) may pose a higher dementia risk than short-acting ones.

However, the overall cumulative dose and duration of use appear to be more important factors than the specific medication.

Does long-term benzodiazepine exposure pose a greater dementia risk for individuals with pre-existing health issues or mood disorders?

Individuals with certain risk factors, such as a chronic illness or existing mental health conditions affecting memory and mood regulation, may be at higher risk for long term dementia risk from prolonged benzodiazepine exposure.

These underlying vulnerabilities can interact with the effects of benzodiazepines, potentially increasing the likelihood of cognitive decline beyond that associated with the drug’s impact on healthy brains or its potential to induce physical dependence.

Can benzodiazepine use affect younger adults’ brain health long term?

While most research focuses on the elderly population, prolonged benzodiazepine use in younger adults may still affect brain function, especially with high doses or misuse.

Do anticholinergic drugs and benzodiazepines increase dementia risk when combined?

Studies have found anticholinergic drug usage to be associated with increased risk of dementia. With this already being established, there might also be a risk of dementia if an anticholinergic drug is combined with benzodiazepine use.

Can stopping benzodiazepines improve memory and cognitive function?

In some cases, yes. Gradual withdrawal under medical supervision may help mild cognitive impairment caused by benzos, as studies have found.

Can benzodiazepines interfere with dementia medications?

Generally, clinicians tend to avoid prescribing benzodiazepines to older people with dementia because these drugs are linked to fall-related injuries and cognitive decline.

Does gender affect the dementia risk from benzodiazepine use?

Current data is mixed. However, studies suggest female patients may be more vulnerable to dementia. However, more research is needed to confirm a gender-based risk difference.

Conclusion

The relationship between long term benzodiazepine use and dementia risk is a complex and evolving area of research. While some studies have identified a concerning association, particularly with extended use and higher doses, the challenge of distinguishing causation from correlation remains.

It’s crucial to acknowledge that the conditions for which benzodiazepines are prescribed, anxiety, insomnia, and depression, are themselves linked to an increased risk of dementia.

Nevertheless, the growing body of evidence strongly suggests that caution is warranted, especially in older adults and those with existing risk factors for dementia.

Disclaimer

The information provided in this article is for educational and informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Always seek the guidance of a qualified healthcare provider or addiction specialist with any questions you may have regarding a medical condition or treatment options. Never disregard professional medical advice or delay seeking treatment because of something you have read on this website.

Charles River Recovery is not liable for any decisions made or actions taken based on the information provided here. If you are in crisis or need immediate help, please contact emergency services or call a licensed treatment provider immediately.

Medically Reviewed by Dr. Salah Alrakawi

Dr. Salah Alrakawi brings over 30 years of expertise in clinical medicine, academia, and administration. He is dual board-certified in Internal Medicine and Addiction Medicine, reflecting his deep commitment to providing comprehensive, patient-centered care.

We’re Here to Help

Get Help Today. We accept most insurance plans.

Get started today

Available 24/7

We accept most insurance plans.

Dr. Salah Alrakawi

Dr. Salah Alrakawi brings over 30 years of expertise in clinical medicine, academia, and administration. He is dual board-certified in Internal Medicine and Addiction Medicine, reflecting his deep commitment to providing comprehensive, patient-centered care.

Currently serving as the Medical Director at Charles River Recovery, Dr. Alrakawi also holds roles as an Attending Physician in the Department of General Internal Medicine at Brigham and Women’s Hospital, Atrius Health, and the Massachusetts Alcohol and Substance Abuse Center (MASAC). His multifaceted work underscores his dedication to advancing both the treatment of addiction and general internal medicine.

Dr. Alrakawi earned his medical degree from Damascus University and completed his Internal Medicine residency at Woodhull Medical Center. He is also a valued member of the teaching faculty at Harvard Medical School, where he helps shape the next generation of physicians.

Throughout his career, Dr. Alrakawi has been recognized with numerous awards and honors from the Massachusetts Department of Public Health, Tufts University School of Medicine, Tufts Medical Center, Lemuel Shattuck Hospital, and Brigham and Women’s Hospital, highlighting his contributions to public health, education, and patient care.

Beyond his professional endeavors, Dr. Alrakawi is an avid traveler who enjoys hiking, playing soccer, and immersing himself in diverse cultures around the world.

Steven Barry

Steven Barry holds a B.A. in Economics from Bates College with extensive professional experience in both financial and municipal management. In his role as Director of Outreach, Steve leads the Charles River team in fostering relationships across the recovery community, local cities and towns, labor partners, and serving as a general resource for anyone seeking help.

Steve’s Charles River Why – “Anything I have ever done in my professional career has been rooted in helping people.  There is no more direct correlate to that end than assisting people find their path to reclaim their life from the grips of addiction”. 

Jillian Martin
Jillian Martin, the Director of Clinical Services, brings over 15 years of experience in behavioral healthcare and more than a decade in national executive clinical leadership. She holds a Bachelor’s degree in Behavioral Science from Concordia College in Bronxville, NY, combining psychology and sociology, and a Master of Science in Marriage and Family Therapy from Eastern Nazarene College. Licensed as an LADC I and LMHC, she is also EMDR-trained. Her diverse background spans patient care in various settings, including inpatient treatment for underserved populations, utilizing an eclectic approach and innovative therapies to enhance patient experiences across levels of care. Jillian enjoys planning adventures, living life to the fullest, and spending quality time with her son.